RxDoctor Payments Data

George Brasinikas, MD

Clinical Pathology/Laboratory Medicine · Gallup, NMNPI 1538114731

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $175,161 of the $175,161 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Kedplasma LLC.

$175,161in general payments, 2019–2025

Across 76 payments — averaging $2304.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kedplasma LLC$175K

What the payments were for

  • Consulting fees$175,161100%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Kedplasma LLC76$175,161

How this compares

Too few clinical pathology/laboratory medicine providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$20,512
Medicare patients
284
Services billed
668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Gallup

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →